Rice Hall James & Associates’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.72M	Buy	142,320 +4,804	+3%	+$227K	0.36%	69
2025 Q1	$5.37M	Buy	137,516 +26,383	+24%	+$1.03M	0.32%	69
2024 Q4	$6.02M	Buy	111,133 +35,664	+47%	+$1.93M	0.33%	69
2024 Q3	$3.81M	Buy	+75,469	New	+$3.81M	0.21%	110